Table 2 List of mononuclear antibodies
From: Biohybrid cochlear implants in human neurosensory restoration
BM-MNC | ||
|---|---|---|
Patient 1 | Patient 2 | |
Characterisation of depleted bone marrow | ||
Total CD45– cells (%) | 64.9 | 98.4 |
Total CD45+ cells (WBCs) (%) | 35.0 | 1.7 |
Viability (%) | 97.1 | 99.7 |
CHECK CD45–/7AAD– cells (SS/FS) (%) | 23.4 | 17.3 |
Viable CD45+/7AAD–/CD34+ cells (%) | 0.55 | 0.96 |
Characterisation of progenitor cells among | ||
Viable CD45–/7AAD–/CD105+ cells (%) | 0.8 | 0.1 |
Viable CD45–/7AAD–/CD73+ cells (%) | 0.5 | 1.0 |
Viable CD45–/7AAD–/CD166+ cells (%) | 0.1 | 0.01 |
Viable CD45–/7AAD–/CD90+ cells (%) | 0.5 | 0.2 |
Viable CD45–/7AAD–/CD14+ cells (%) | 0.4 | 0.6 |
Viable CD45–/7AAD–/CD3+ cells (%) | 0.03 | 0.1 |
Viable CD45–/7AAD–/CD34+ cells (%) | 0.1 | 0.01 |